Fortis Healthcare: Investor Rakesh Jhunjhunwala has upped his stake in this hospitals chain, bringing his current portfolio holding to 4.3%. The company’s share price has been in bullish territory, and is trading above all its SMAs. Over the past one year however it has not been an especially impressive performer, beating the index by just 1.1%.

Gland Pharma: This recently listed pharma company has sparked broker interest in recent weeks, and Axis Direct issued a buy call today on the stock following its approval for emergency manufacture of the Sputnik V vaccine. “Gland Pharma could add ~INR 1,500 crore sales (EBITDA margins 15%) and could add incremental EPS of INR 6.4,” the analysts wrote.

Vaibhav Global: This e-retailer continues to defy market jitters and climb upward this week, and at this point has beat Nifty50 returns by over 380%. Strong demand had led management in Feb to up its growth guidance to 18-20% in constant currency from the earlier 15-17% after the company’s Q3 results.

Gujarat Fluorochemicals: This chemicals company has been seeing rising delivery on high volumes, and hit a new year high in the past week. See all stocks with high delivery volumes compared to the previous day.  

Thyrocare Technologies: This healthcare services company CEO didn’t last long in his seat - CEO Arindam Haldar had joined the company in September 2020. He resigned in an unexpected move for the Board, which waited to see if he would reconsider. But he confirmed his resignation citing “personal reasons” on April 8.